Starting in 1996, the Vancouver Injection Drug User Study now demonstrates how incarceration creates more harm than benefit for injection drug users.

Over the past 20 years studies have shown the efficacy of using marijuana in medicine specifically its psychoactive ingredient, tetrahydrocannabinol. Forty billion dollars is the number of dollars up for grabs in the North American pharma market for pain, anxiety and mood disorders. Cannasat Therapeutics Inc, a junior drug developer located in Canada, is now targeting those conditions with treatments inspired by cannabis sativa.